ArticleHaematologica2016

Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia.

Kathy L McGraw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.